The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Partridge Andrew John since 2021.
This trader's CIK number is 1758838.
At the time of last reporting, Partridge Andrew John was the Chief Growth Officer of Grail, Inc.. (stock ticker symbol GRAL).
Also see all insider trading activities at Grail, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | TPTX | 0 | $0 | 221 | $8,022 | 0 | $0 |
| 2021 | TPTX | 0 | $0 | 1,869 | $139,988 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | GRAL | 0 | $0 | 1,491 | $91,070 | 0 | $0 |
1. Turning Point Therapeutics, Inc. (TPTX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-02-09 | TPTX | Sale | 221 | 36.30 | 8,022 |
| 2021-07-14 | TPTX | Sale | 1,869 | 74.90 | 139,988 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-06-04 | GRAL | Sale | 1,491 | 61.08 | 91,070 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Partridge Andrew John (Chief Growth Officer of Grail, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.